InvestorsHub Logo
icon url

BonelessCat

08/12/16 3:29 PM

#156673 RE: MinnieM #156672

I suspect they will be partnering both to pay for Kevetrin trials. Two Phase 2 drugs should bring several $100 million upfront with regular milestone payments to approval and market. The money will pay for a lot of Kevetrin development across half a dozen cancer types.

icon url

To infinity and beyond!

08/12/16 3:46 PM

#156675 RE: MinnieM #156672

maybe, but what is a positive study if there are no controls?